IT IS AGREED:Research Agreement • March 31st, 2005 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Connecticut
Exhibit 10.28 February 10, 2005 Leonard P. Paplauskas Associate Vice President for Research Administration University of Connecticut Health Center Center for Science and Technology Commercialization 263 Farmington Avenue Farmington, CT 06030 RE:...Research Agreement • March 31st, 2005 • Antigenics Inc /De/ • Biological products, (no disgnostic substances)
This letter is in reference to that certain Research Agreement by and between University of Connecticut Health Center ("UCHC") and Antigenics Inc., a Delaware corporation ("Antigenics Inc.")(each a "Party" and collectively the "Parties") dated February 28, 1998 ("Agreement"), as amended by Amendment No. 1 Research Agreement dated April 19, 2002, further amended by Amendment Agreement dated March 18, 2003, and further amended by Amendment No. 2 to Research Agreement dated December 30, 2003 (each singly an "Amendment", collectively the "Agreement"). In accordance with the provisions of Section 5.0 of the Agreement, Antigenics Inc. hereby agrees to pay UCHC an additional one-time payment in the sum of One Hundred Thirty-Five Thousand dollars ($135,000) for additional costs associated with activities to be performed under the Agreement in 2005.
